Related Experiment Video
Updated: Sep 2, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
A Focus on Special Populations in Relapsed Multiple Myeloma
Mary Steinbach1, Kathleen Colson2, Beth Faiman3
1Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Healthcare disparities impact multiple myeloma patient outcomes. Addressing individual needs and promoting clinical trial access are crucial for optimal care, especially for patients with advanced disease.
Area of Science:
- Oncology
- Health Disparities Research
- Patient Care Management
Background:
- Multiple myeloma care presents universal challenges, yet significant health disparities exist.
- These disparities, based on race, ethnicity, socioeconomic status, and other factors, can lead to suboptimal patient care and poorer outcomes.
- Patients with multiple myeloma, particularly those who have undergone multiple lines of therapy, face risks like genetic changes, rapid relapse, and disease sequelae.
Purpose of the Study:
- To highlight the challenges in managing multiple myeloma care.
- To emphasize the impact of health disparities on patient outcomes.
- To advocate for individualized care and clinical trial participation.
Main Methods:
- Review of current challenges in multiple myeloma patient care.
- Analysis of how health disparities affect treatment and outcomes.
- Discussion of management strategies for patients with advanced disease.
Main Results:
- Health disparities negatively affect care quality and outcomes for diverse patient groups.
- Patients with multiple relapses may develop genetic mutations and experience severe disease sequelae.
- Multiple treatment options are available for patients within their first three relapses.
Conclusions:
- Individualized patient circumstances must guide multiple myeloma care, considering potential disparities.
- Clinicians should actively discuss clinical trial options with all patients, irrespective of disparities.
- Close monitoring and provision of resources are essential for patients facing disparities to ensure optimal disease and organ surveillance.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...